Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphomaMi Kwon, Pere Barba, Gloria Iacoboni et al.|Haematologica|2022Cited by 131
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL studyFranck Morschhauser, Loretta J. Nastoupil, Juan Luis Reguera Ortega et al.|Nature Medicine|2024Cited by 127